Literature DB >> 35331890

Inclusion Criteria for Heart Failure With Preserved Ejection Fraction Clinical Trials: Making the Case for Precision Diagnosis and Greater Inclusivity.

Ravi B Patel1, Sanjiv J Shah2.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 35331890      PMCID: PMC9106892          DOI: 10.1016/j.cardfail.2022.03.345

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   6.592


× No keyword cloud information.
  14 in total

1.  Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction: The INDIE-HFpEF Randomized Clinical Trial.

Authors:  Barry A Borlaug; Kevin J Anstrom; Gregory D Lewis; Sanjiv J Shah; James A Levine; Gabe A Koepp; Michael M Givertz; G Michael Felker; Martin M LeWinter; Douglas L Mann; Kenneth B Margulies; Andrew L Smith; W H Wilson Tang; David J Whellan; Horng H Chen; Victor G Davila-Roman; Steven McNulty; Patrice Desvigne-Nickens; Adrian F Hernandez; Eugene Braunwald; Margaret M Redfield
Journal:  JAMA       Date:  2018-11-06       Impact factor: 56.272

2.  Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial.

Authors:  Marc A Pfeffer; Brian Claggett; Susan F Assmann; Robin Boineau; Inder S Anand; Nadine Clausell; Akshay S Desai; Rafael Diaz; Jerome L Fleg; Ivan Gordeev; John F Heitner; Eldrin F Lewis; Eileen O'Meara; Jean-Lucien Rouleau; Jeffrey L Probstfield; Tamaz Shaburishvili; Sanjiv J Shah; Scott D Solomon; Nancy K Sweitzer; Sonja M McKinlay; Bertram Pitt
Journal:  Circulation       Date:  2014-11-18       Impact factor: 29.690

3.  Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial.

Authors:  Alvin Chandra; Muthiah Vaduganathan; Eldrin F Lewis; Brian L Claggett; Adel R Rizkala; Wenyan Wang; Martin P Lefkowitz; Victor C Shi; Inder S Anand; Junbo Ge; Carolyn S P Lam; Aldo P Maggioni; Felipe Martinez; Milton Packer; Marc A Pfeffer; Burkert Pieske; Margaret M Redfield; Jean L Rouleau; Dirk J Van Veldhuisen; Faiez Zannad; Michael R Zile; John J V McMurray; Scott D Solomon
Journal:  JACC Heart Fail       Date:  2019-07-10       Impact factor: 12.035

4.  Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial.

Authors:  Sanjiv J Shah; Barry A Borlaug; Eugene S Chung; Donald E Cutlip; Philippe Debonnaire; Peter S Fail; Qi Gao; Gerd Hasenfuß; Rami Kahwash; David M Kaye; Sheldon E Litwin; Philipp Lurz; Joseph M Massaro; Rajeev C Mohan; Mark J Ricciardi; Scott D Solomon; Aaron L Sverdlov; Vijendra Swarup; Dirk J van Veldhuisen; Sebastian Winkler; Martin B Leon
Journal:  Lancet       Date:  2022-02-01       Impact factor: 79.321

5.  Under-Enrollment of Obese Heart Failure with Preserved Ejection Fraction Patients in Major HFpEF Clinical Trials.

Authors:  Joban Vaishnav; Lisa R Yanek; Virginia S Hahn; Eunice Yang; Rishi Trivedi; David A Kass; Kavita Sharma
Journal:  J Card Fail       Date:  2021-12-18       Impact factor: 5.712

6.  Empagliflozin in Heart Failure with a Preserved Ejection Fraction.

Authors:  Stefan D Anker; Javed Butler; Gerasimos Filippatos; João P Ferreira; Edimar Bocchi; Michael Böhm; Hans-Peter Brunner-La Rocca; Dong-Ju Choi; Vijay Chopra; Eduardo Chuquiure-Valenzuela; Nadia Giannetti; Juan Esteban Gomez-Mesa; Stefan Janssens; James L Januzzi; Jose R Gonzalez-Juanatey; Bela Merkely; Stephen J Nicholls; Sergio V Perrone; Ileana L Piña; Piotr Ponikowski; Michele Senni; David Sim; Jindrich Spinar; Iain Squire; Stefano Taddei; Hiroyuki Tsutsui; Subodh Verma; Dragos Vinereanu; Jian Zhang; Peter Carson; Carolyn Su Ping Lam; Nikolaus Marx; Cordula Zeller; Naveed Sattar; Waheed Jamal; Sven Schnaidt; Janet M Schnee; Martina Brueckmann; Stuart J Pocock; Faiez Zannad; Milton Packer
Journal:  N Engl J Med       Date:  2021-08-27       Impact factor: 176.079

7.  Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.

Authors:  Scott D Solomon; John J V McMurray; Inder S Anand; Junbo Ge; Carolyn S P Lam; Aldo P Maggioni; Felipe Martinez; Milton Packer; Marc A Pfeffer; Burkert Pieske; Margaret M Redfield; Jean L Rouleau; Dirk J van Veldhuisen; Faiez Zannad; Michael R Zile; Akshay S Desai; Brian Claggett; Pardeep S Jhund; Sergey A Boytsov; Josep Comin-Colet; John Cleland; Hans-Dirk Düngen; Eva Goncalvesova; Tzvetana Katova; Jose F Kerr Saraiva; Małgorzata Lelonek; Bela Merkely; Michele Senni; Sanjiv J Shah; Jingmin Zhou; Adel R Rizkala; Jianjian Gong; Victor C Shi; Martin P Lefkowitz
Journal:  N Engl J Med       Date:  2019-09-01       Impact factor: 91.245

8.  Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial.

Authors:  Javed Butler; Gerasimos Filippatos; Tariq Jamal Siddiqi; Martina Brueckmann; Michael Böhm; Vijay K Chopra; João Pedro Ferreira; James L Januzzi; Sanjay Kaul; Ileana L Piña; Piotr Ponikowski; Sanjiv J Shah; Michele Senni; Ola Vedin; Subodh Verma; Barbara Peil; Stuart J Pocock; Faiez Zannad; Milton Packer; Stefan D Anker
Journal:  Circulation       Date:  2021-11-15       Impact factor: 39.918

9.  The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial.

Authors:  Michael E Nassif; Sheryl L Windsor; Barry A Borlaug; Dalane W Kitzman; Sanjiv J Shah; Fengming Tang; Yevgeniy Khariton; Ali O Malik; Taiyeb Khumri; Guillermo Umpierrez; Sumant Lamba; Kavita Sharma; Sadiya S Khan; Lokesh Chandra; Robert A Gordon; John J Ryan; Sunit-Preet Chaudhry; Susan M Joseph; Chen H Chow; Manreet K Kanwar; Michael Pursley; Elias S Siraj; Gregory D Lewis; Barry S Clemson; Michael Fong; Mikhail N Kosiborod
Journal:  Nat Med       Date:  2021-10-28       Impact factor: 53.440

10.  Effects of Sacubitril/Valsartan on N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Ejection Fraction.

Authors:  Jonathan W Cunningham; Muthiah Vaduganathan; Brian L Claggett; Michael R Zile; Inder S Anand; Milton Packer; Faiez Zannad; Carolyn S P Lam; Stefan Janssens; Pardeep S Jhund; Lars Kober; Jean Rouleau; Sanjiv J Shah; Vijay K Chopra; Victor C Shi; Martin P Lefkowitz; Margaret F Prescott; Marc A Pfeffer; John J V McMurray; Scott D Solomon
Journal:  JACC Heart Fail       Date:  2020-03-30       Impact factor: 12.035

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.